Prescription drug · ANDA
Dipyridamole NDC 70518-4650
Dipyridamole 50 mg/1 · Tablet, Film coated · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4650-0 | 70518465000 | 50 POUCH in 1 BOX (70518-4650-0) / 1 TABLET, FILM COATED in 1 POUCH (70518-4650-1)Marketed from Apr 29, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dipyridamole
- Generic name (nonproprietary)
- dipyridamole
- Active ingredients
- Dipyridamole — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040874
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Platelet Aggregation (Physiologic effect)
- Identifiers
- Product ID 70518-4650_509b6d30-eda6-417e-e063-6294a90a4a94SPL ID 509b6d30-eda6-417e-e063-6294a90a4a94SPL set ID 226099e2-70bb-4b9b-bb52-c20fbca2aec5RxCUI 197622UNII 64ALC7F90C
- Pharmacologic class
- Platelet Aggregation Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518465000followed by a unit qualifier and the quantityPackage 70518-4650-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040874
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dipyridamole | Dipyridamole 50 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-663 |
| Dipyridamole | Dipyridamole 25 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-662 |
| Dipyridamole | Dipyridamole 75 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-664 |
| Dipyridamole | Dipyridamole 25 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-187 |
| Dipyridamole | Dipyridamole 50 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-188 |
| Dipyridamole | Dipyridamole 75 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-189 |